Zobrazeno 1 - 3
of 3
pro vyhledávání: '"T D Bethke"'
Autor:
T D Bethke, Romuald J. Adamek
Publikováno v:
American Journal of Gastroenterology. 93:1919-1924
OBJECTIVE: Eradication of Helicobacter pylori (H. pylori) is recommended as the first-line therapeutic concept for reliable long-term prevention of duodenal ulcer (DU) relapse. Current treatment regimens vary in efficacy, complexity, and compliance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03366864319fad63e53bfa94c71c096c
https://doi.org/10.1111/j.1572-0241.1998.459_a.x
https://doi.org/10.1111/j.1572-0241.1998.459_a.x
Publikováno v:
International journal of clinical pharmacology and therapeutics. 49(6)
UNLABELLED Roflumilast is a novel, orally active, selective phosphodiesterase 4 inhibitor recently approved for the treatment of severe COPD. The pharmacological effect is mediated mainly by its active metabolite roflumilast N-oxide. OBJECTIVE This d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2aaec8b0a90b85cf9b28e3732420fbc
https://pubmed.ncbi.nlm.nih.gov/21612746
https://pubmed.ncbi.nlm.nih.gov/21612746
Autor:
R J, Adamek, T D, Bethke
Publikováno v:
The American journal of gastroenterology. 93(10)
Eradication of Helicobacter pylori (H. pylori) is recommended as the first-line therapeutic concept for reliable long-term prevention of duodenal ulcer (DU) relapse. Current treatment regimens vary in efficacy, complexity, and compliance. To assess t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::188c15e138d4cc30c010830d042cdd4f
https://pubmed.ncbi.nlm.nih.gov/9772056
https://pubmed.ncbi.nlm.nih.gov/9772056